-
Latest in HIV/AIDS
Left RightThe month after ACS risky for patients with HIV
Reuters Health • The Doctor's Channel Daily Newscast
1:44 | Posted on Jan 10, 2012 in Cardiology, HIV/AIDS, Infectious Diseases, Reuters Health • The Doctor's Channel Daily NewscastNEW YORK (Reuters Health) – Patients with HIV infection who are admitted to the hospital with acute coronary syndrome (ACS) face a “substantial” risk of dying in the short-term and a significant risk of needing revascularization and suffering...
More in HIV/AIDS
Benefit of rituximab-EPOCH for HIV-related lymphoma confirmed
Reuters Health • The Doctor's Channel Daily Newscast
1:28 | Posted on Dec 29, 2011 in
Hematology-Oncology, HIV/AIDS, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – A pooled analysis of two trials indicates that HIV patients with aggressive B-cell non-Hodgkin lymphoma (NHL) fare better with a regimen of rituximab combined with EPOCH chemotherapy than rituximab plus CHOP chemotherapy.
“Benefits were observed in both high-risk and...
“Tail” regimens reduce viral resistance after intrapartum nevirapine in HIV-positive women
Reuters Health • The Doctor's Channel Daily Newscast
1:48 | Posted on Dec 27, 2011 in
HIV/AIDS, Infectious Diseases, Neonatology, Ob/Gyn, Pediatrics, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – In pregnant HIV-infected women treated with a single intrapartum dose of nevirapine (NVP) to prevent vertical HIV transmission, the subsequent selection of nevirapine-resistant virus can be substantially reduced with various short-term antiretroviral “tail” regimens.
The...
Moxifloxacin or amoxicillin/clavulanate effective for COPD exacerbations
Reuters Health • The Doctor's Channel Daily Newscast
1:32 | Posted on Dec 27, 2011 in
HIV/AIDS, Infectious Diseases, Neonatology, Ob/Gyn, Pediatrics, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Moxifloxacin is as effective as amoxicillin/clavulanic acid in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in the outpatient setting, according to the results of the MAESTRAL trial reported in the European Respiratory Journal online December...
Amphotericin B plus fluconazole a good option for HIV-associated meningitis
1:35
|
Nov 21, 2011
LAM assay not ready for routine use: review
1:35
|
Jul 26, 2011
Bone density stabilizes in HIV patients on HAART
1:42
|
Jul 12, 2011
Triple antiretroviral therapy improves pregnancy outcomes
2:11
|
Jun 30, 2011
Immediate ART not beneficial in HIV-related tuberculous meningitis
1:38
|
Jun 15, 2011
Niacin/fenofibrate combo helps correct HIV-related dyslipidemia
1:53
|
May 23, 2011
ICAMiA’s AIDS Training Program
2:33
|
May 20, 2011
ICAMiA’s Work with PEPFAR
1:32
|
May 20, 2011
Initiating anti-HIV therapy at high CD4 count increases AIDS-free survival
1:41
|
Apr 21, 2011
Combined four-drug fixed-dose regimen effective for treating TB
1:46
|
Apr 14, 2011
Importance of Holistic Approach to AIDS Work in Africa
1:39
|
Apr 12, 2011
Minority HIV drug resistance mutations influence initial treatment success
2:23
|
Apr 8, 2011
New Anti-AIDS Drug Treatments
1:32
|
Apr 7, 2011
AIDS Statistics in Africa and Elsewhere
1:22
|
Apr 7, 2011
Israel Consortium on AIDS Medicine in Africa
1:37
|
Mar 31, 2011
HIV patients at increased risk of bone fractures
2:36
|
Mar 21, 2011
Brain injury, cognitive impairment continue in HIV infection, despite HAART
1:59
|
Feb 25, 2011
Efficacy of atazanavir/ritonavir similar to efavirenz as part of an initial 3-drug HIV regimen
2:28
|
Feb 15, 2011
Type of statins given to HIV-infected people should be reconsidered: study
1:26
|
Jan 5, 2011
Effect of switching from efavirenz to etravirine on CNS side effects unclear
2:24
|
Dec 7, 2010
HIV-related facial lipoatrophy can be corrected with plastic surgery
1:35
|
Nov 17, 2010
Efavirenz or lopinavir/ritonavir both effective in first treatment of patients with AIDS
2:01
|
Oct 26, 2010
Maintenance HIV treatment with boosted lopinavir monotherapy not effective
1:41
|
Oct 5, 2010
Prednisone reduces complications of immune reconstitution syndrome
1:09
|
Sep 29, 2010
